Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease
Coronary Artery Disease,  Clinical Article

Suzuki T et al. – Combination therapy of renin–angiotensin system (RAS) inhibitor with statin is more effective than statin alone in inhibiting atherosclerotic progression of coronary arteries and the aorta in patients with coronary artery disease.

Methods
  • Using 64 multislice computed tomography,
  • Vessel wall areas (VWAs) and total vascular areas of the left main trunk (LMT) and proximal right coronary artery (RCA) and the thoracic descending aorta (TDA) were determined in patients with coronary artery disease before and after 2.0–year treatment with atorvastatin and candesartan (n=20) or with atorvastatin alone (n=16).
  • Although these patients had been treated with the combination therapy or statin alone at the study enrollment.
  • Plasma levels of high sensitive C–reactive protein, matrix metalloproteinase–9, and urinary 8–iso–prostaglandin F2 α were determined at the baseline.

Results
  • There were no significant differences in low–density lipoprotein and high–density lipoprotein cholesterol, C–reactive protein, matrix metalloproteinase–9, or urinary 8–iso–prostaglandin F2 α levels between the two groups.
  • Two years later, total vascular areas of TDA and RCA increased significantly in the atorvastatin group but not in the combination group.
  • Moreover, increases in VWAs were less in the combination group than in the atorvastatin group in TDA (3.6±23.1 vs. 28.6±25.5 mm2, P=0.004), RCA (?1.6±1.6 vs. 0.6±2.5 mm2, P=0.005), and left main trunk (?0.9±3.5 vs. 1.3±2.4 mm2, P=0.095).
  • Biomarker levels at the baseline did not affect the progression of VWA.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pharmacy

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharmacy Articles

1 Precautionary labelling of foods for allergen content: Are we ready for a global framework? Full Text World Allergy Organization Journal, May 8, 2014    Free full text    Review Article

2 A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: Sorafenib for second line renal cell cancer Full Text Cost Effectiveness and Resource Allocation, May 5, 2014    Free full text

3 New cholesterol guideline: LDL goals take backseat to statins Full Text American Pharmacists Association News, November 15, 2013    Free full text    Clinical Guideline

4 Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications Full Text Journal of Pharmacy and Pharmaceutical Sciences, January 3, 2014    Free full text    Clinical Article

5 Bedtime aspirin may be more beneficial for heart patients Full Text Pharmacy Times, December 2, 2013    Free full text    Clinical Article

6 Are chromium supplements helpful in lowering blood sugar levels? Full Text EurekAlert!, April 10, 2014    Free full text

7 Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents Expert Opinion on Pharmacotherapy, March 17, 2014    Review Article

8 Beyond statins: new lipid lowering strategies to reduce cardiovascular risk Current Atherosclerosis Reports, May 21, 2014    Review Article    Clinical Article

9 Efficacy and tolerability of carbamazepine for the treatment of painful diabetic neuropathy in adults: a 12-week, open-label, multicenter study Full Text International Journal of General Medicine, July 21, 2014    Free full text    Clinical Article

10 Unexpected results in cancer drug trial Full Text EurekAlert!, April 9, 2014    Free full text

11 Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: Clinical and economic consequences PharmacoEconomics, February 11, 2014    Clinical Article

12 Cost-effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial PLOS ONE, April 15, 2014    Review Article

13 HPV eradicated by AHCC supplement, preclinical study suggests Full Text EurekAlert!, March 24, 2014    Free full text

14 A systematic review: Can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins? Clinical Infectious Diseases, July 25, 2014    Clinical Article

15 Vancomycin, metronidazole, or tolevamer for clostridium difficile infection: Results from two multinational, randomized, controlled trials Clinical Infectious Diseases, June 6, 2014    Clinical Article

16 Prescribing of high-dose acetaminophen products discouraged Full Text U.S. Pharmacist, March 11, 2014    Free full text    Clinical Article

17 Impact of a new method of warfarin management on patient satisfaction, time, and cost Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, August 23, 2013    Clinical Article

18 Clever chemistry improves a new class of antibiotics Full Text EurekAlert!, January 20, 2014    Free full text

19 Beta-blockers in heart failure with preserved ejection fraction: A meta-analysis Heart Failure Reviews, July 28, 2014    Evidence Based Medicine    Review Article    Clinical Article

20 Beta-lactam allergy: Clinical implications and costs Full Text Clinical and Molecular Allergy , December 4, 2013    Free full text    Clinical Article

Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacistmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close